Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Agios Blood Cancer Drug Heading to Early FDA Filing by Partner Celgene
Agios Blood Cancer Drug Heading to Early FDA Filing by Partner Celgene
Agios Blood Cancer Drug Heading to Early FDA Filing by Partner Celgene
Submitted by
admin
on September 7, 2016 - 8:16pm
Source:
TheStreet.com
News Tags:
Agios
FDA
Celgene
acute myeloid leukemia
AG-221
Headline:
Agios Blood Cancer Drug Heading to Early FDA Filing by Partner Celgene
Do Not Allow Advertisers to Use My Personal information
